Literature DB >> 30554346

Skeletal fragility: an emerging complication of Ehlers-Danlos syndrome.

Anna Maria Formenti1, Mauro Doga2, Stefano Frara2, Marco Ritelli3, Marina Colombi3, Giuseppe Banfi1,2, Andrea Giustina4.   

Abstract

Ehlers-Danlos syndrome (EDS) is an emerging cause of skeletal fragility. Mechanism of bone damage are probably multifactorial in line with the different skeletal phenotypes that can be found in clinical practice. A structured approach to clinical management of bone metabolic complication in EDS is proposed.

Entities:  

Keywords:  Bone mineral density; Bone structure; Ehlers–Danlos syndrome; Osteoporosis; Vertebral fractures

Year:  2018        PMID： 30554346     DOI： 10.1007/s12020-018-1822-y

Source DB:  PubMed          Journal:  Endocrine        ISSN： 1355-008X            Impact factor:   3.633


  36 in total

1.  Diagnosis of Recurrent Fracture in a Pediatric Cohort.

Authors:  M Fiscaletti; C P Coorey; A Biggin; J Briody; D G Little; A Schindeler; C F Munns
Journal:  Calcif Tissue Int       Date:  2018-06-25       Impact factor: 4.333

2.  Urinary Cross-linked N-terminal Telopeptide of Type I Collagen Levels of Infants with Osteogenesis Imperfecta and Healthy Infants.

Authors:  Miho Yamashita; Kosei Hasegawa; Yousuke Higuchi; Takayuki Miyai; Ayumi Okada; Hiroyuki Tanaka; Hirokazu Tsukahara
Journal:  Acta Med Okayama       Date:  2016-12       Impact factor: 0.892

Review 3.  Pituitary Diseases and Bone.

Authors:  Gherardo Mazziotti; Stefano Frara; Andrea Giustina
Journal:  Endocr Rev       Date:  2018-08-01       Impact factor: 19.871

Review 4.  New understanding and treatments for osteoporosis.

Authors:  G Mazziotti; J Bilezikian; E Canalis; D Cocchi; A Giustina
Journal:  Endocrine       Date:  2012-02       Impact factor: 3.633

5.  Osteoporosis, a unitary hypothesis of collagen loss in skin and bone.

Authors:  Sam Shuster
Journal:  Med Hypotheses       Date:  2005       Impact factor: 1.538

6.  Ehlers Danlos syndrome and osteoporosis.

Authors:  A A Deodhar; A D Woolf
Journal:  Ann Rheum Dis       Date:  1994-12       Impact factor: 19.103

7.  Bone density in Ehlers-Danlos syndrome.

Authors:  L Carbone; F A Tylavsky; A J Bush; W Koo; E Orwoll; S Cheng
Journal:  Osteoporos Int       Date:  2000       Impact factor: 4.507

Review 8.  Osteogenesis imperfecta: diagnosis and treatment.

Authors:  Telma Palomo; Tatiane Vilaça; Marise Lazaretti-Castro
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2017-12       Impact factor: 3.243

Review 9.  Contemporary approach to joint hypermobility and related disorders.

Authors:  Marco Castori; Alan Hakim
Journal:  Curr Opin Pediatr       Date:  2017-12       Impact factor: 2.856

10.  Clinical and molecular characterization of 40 patients with classic Ehlers-Danlos syndrome: identification of 18 COL5A1 and 2 COL5A2 novel mutations.

Authors:  Marco Ritelli; Chiara Dordoni; Marina Venturini; Nicola Chiarelli; Stefano Quinzani; Michele Traversa; Nicoletta Zoppi; Annalisa Vascellaro; Anita Wischmeijer; Emanuela Manfredini; Livia Garavelli; Piergiacomo Calzavara-Pinton; Marina Colombi
Journal:  Orphanet J Rare Dis       Date:  2013-04-12       Impact factor: 4.123
View more
  6 in total

Review 1.  Bone Disease in Patients with Ehlers-Danlos Syndromes.

Authors:  Shuaa Basalom; Frank Rauch
Journal:  Curr Osteoporos Rep       Date:  2020-04       Impact factor: 5.096

Review 2.  Risk of vertebral fractures in hypoparathyroidism.

Authors:  Anna Maria Formenti; Francesco Tecilazich; Raffaele Giubbini; Andrea Giustina
Journal:  Rev Endocr Metab Disord       Date:  2019-09       Impact factor: 6.514

Review 3.  Hyperprolactinemia and bone.

Authors:  Luigi di Filippo; Mauro Doga; Eugenia Resmini; Andrea Giustina
Journal:  Pituitary       Date:  2020-06       Impact factor: 4.107

4.  Are patients with hypermobile Ehlers-Danlos syndrome or hypermobility spectrum disorder so different?

Authors:  Bérengère Aubry-Rozier; Adrien Schwitzguebel; Flore Valerio; Joelle Tanniger; Célia Paquier; Chantal Berna; Thomas Hügle; Charles Benaim
Journal:  Rheumatol Int       Date:  2021-08-16       Impact factor: 2.631

5.  Clinical and Molecular Characterization of Classical-Like Ehlers-Danlos Syndrome Due to a Novel TNXB Variant.

Authors:  Daisy Rymen; Marco Ritelli; Nicoletta Zoppi; Valeria Cinquina; Cecilia Giunta; Marianne Rohrbach; Marina Colombi
Journal:  Genes (Basel)       Date:  2019-10-25       Impact factor: 4.096

6.  Multisystemic manifestations in a cohort of 75 classical Ehlers-Danlos syndrome patients: natural history and nosological perspectives.

Authors:  Marco Ritelli; Marina Venturini; Valeria Cinquina; Nicola Chiarelli; Marina Colombi
Journal:  Orphanet J Rare Dis       Date:  2020-07-31       Impact factor: 4.123
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.